FDA Adverse Event Malfunction Summary report: N

DETERMINE HIV-1/2 AG/AB COMBO 25T

MDR report key: 23223032 · Received October 6, 2025

Report

Report Number
1221359-2025-00418
Event Type
Malfunction
Date Received
October 6, 2025
Date of Event
April 9, 2025
Report Date
October 6, 2025
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Product Code
MZF
PMA / PMN Number
BP120037
Removal / Correction Number
1221359-07/31/2025-002-C
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ON RETAINED KIT LOT 0000939868 WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 7D2648/LOT 0000939868, DEVICE PART NUMBER 10732998/LOT 944760. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED AS FALSE POSITIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 0000939868 SHOWED THAT THE COMPLAINT RATE IS (B)(4). AS PART OF AN INVESTIGATION INTO PRELIMINARY FALSE REACTIVE RESULTS, ABBOTT FOUND THAT FOR KIT LOT 0000939868, THE ROOT CAUSE OF THE RESULTS WAS DUE TO A SUBCOMPONENT USED IN THE MANUFACTURE OF DETERMINE HIV-1/2 AG/AG COMBO. THE ISSUE HAS BEEN ISOLATED TO SPECIFIC LOTS OF THE SUBCOMPONENT, WHICH WERE USED TO MANUFACTURE SPECIFIC TEST KIT LOTS. THE NECESSARY ACTIONS TO PREVENT RECURRENCE HAVE BEEN TAKEN, AND THE CORRECTION OF PRODUCT IN THE FIELD WAS CONDUCTED.

Description of Event or Problem · 0

THE CUSTOMER REPORTED TWO (2) FALSE POSITIVE RESULTS WITH DETERMINE HIV-1/2 AG/AB COMBO TEST PERFORMED ON DIFFERENT DATES. THIS MFR. REPORT ADDRESSES TEST TWO (2) OF TWO (2). THE CUSTOMER REPORTED A FALSE POSITIVE RESULT WITH DETERMINE HIV-1/2 AG/AB COMBO TEST PERFORMED ON (B)(6) 2025 USING FINGERSTICK SAMPLE TYPE. THE CUSTOMER CONFIRMED THAT THE PATIENT REFUSED TO UNDERGO ADDITIONAL TESTING OR EVALUATION. THE CUSTOMER CONFIRMED THAT PATIENT WAS NOT HOSPITALIZED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2263834 DETERMINE HIV-1/2 AG/AB COMBO 25T TEST, HIV DETECTION MZF ABBOTT DIAGNOSTICS SCARBOROUGH, INC. 0000939868

Patients

Seq Age Sex Outcome Treatment
1 43 YR Male